New York (March 2nd, 2013) - MannKind Corp. (NASDAQ: MNKD) announced that it will present at the Cowen and Company 33rd Annual Health Care Conference on March 5, 2013 at 10:40 AM (EST) at the Boston Marriott Copley in Boston, Massachusetts.
MannKind Corporation, a development stage biopharmaceutical company. MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA®, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
Find out if this announcement could benefit MNKD
by getting the free and full trend analysis report here: http://www.monstertradingalerts.com/market-scan/?symbol=MNKD
Opko Health, Inc. (NYSE: OPK) announced that a study published online in Clinical Chemistry, and to be included in the April 2013 print issue, describes the application of OPKO’s point-of-care system to mobile diagnostics, a major advance towards providing people in resource poor settings with laboratory-quality diagnostic services and directly integrating results with cloud-based patient records.
In collaboration with OPKO, Samuel Sia, associate Professor of Biomedical Engineering at Columbia Engineering and cofounder of Claros Diagnostics (now OPKO Diagnostics), has demonstrated that their lab-on-a-chip technology can be used not only to check a patient’s infectious disease status anywhere in the world with just a finger prick, but also synchronize the results automatically and instantaneously with central health-care records.
Find out where OPK
could be headed by getting the free and full report here: http://www.monstertradingalerts.com/market-scan/?symbol=OPK
MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www. MonsterTradingAlerts.com
Disclosure: MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit; http://www.monstertradingalerts.com/disclaimer/
Alexander K. Neumann
Monster Trading Alerts